13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0000919574-25-006891
Total Value
$22.9M
Positions
12
Other Managers
0
Confidential Omitted
Yes
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REZOLUTE INC | RZLT | 1,986,818 | $18.7M | 81.70% |
| 2 | SPDR GOLD TR | GLD | 7,286 | $2.6M | 11.33% |
| 3 | BERKSHIRE HATHAWAY INC DEL | BRK-A | 651 | $327,454 | 1.43% |
| 4 | MIND MEDICINE MINDMED INC | 60255C885 | 27,011 | $318,459 | 1.39% |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 13,097 | $268,106 | 1.17% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 53,503 | $187,260 | 0.82% |
| 7 | BICARA THERAPEUTICS INC | BCAX | 10,941 | $172,760 | 0.76% |
| 8 | KYVERNA THERAPEUTICS INC | KYTX | 22,981 | $137,887 | 0.60% |
| 9 | LEXEO THERAPEUTICS INC | LXEO | 17,332 | $115,084 | 0.50% |
| 10 | INHIBIKASE THERAPEUTICS INC | IKT | 16,393 | $26,557 | 0.12% |
| 11 | SAB BIOTHERAPEUTICS INC | SABSW | 10,935 | $21,979 | 0.10% |
| 12 | CONTEXT THERAPEUTICS INC | CNTX | 18,403 | $17,829 | 0.08% |